Search results
Ionis Pharmaceuticals (IONS) Soars 6.8%: Is Further Upside Left in the Stock?
Zacks via Yahoo News· 1 week agoIonis Pharmaceuticals (IONS) witnessed a jump in share price last session on above-average trading...
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
Zacks via Yahoo News· 1 week agoThe FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat...
The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar...
Zacks via Yahoo News· 1 month agoFor Immediate Release Chicago, IL – May 24, 2024 – Zacks.com announces the list of stocks featured...
Ionis Pharmaceuticals (IONS) Down 0.7% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo News· 1 month agoIt has been about a month since the last earnings report for Ionis Pharmaceuticals (IONS). Shares...
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Zacks via Yahoo News· 2 months agoIonis Pharmaceuticals (IONS) possesses the right combination of the two key ingredients for a likely...
Ionis Pharmaceuticals (IONS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks via Yahoo News· 2 months agoThe headline numbers for Ionis Pharmaceuticals (IONS) give insight into how the company performed in...
Catalyst Pharmaceuticals (CPRX) Rallies 43% YTD: Here's Why
Zacks via Yahoo News· 2 years agoCatalyst's (CPRX) price rallies on the back of the robust performance of its lead drug, Firdapse,...
Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Misses Revenue Estimates
Zacks via Yahoo News· 2 months agoIonis Pharmaceuticals (IONS) delivered earnings and revenue surprises of 10.91% and 9.51%,...
Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
Zacks via Yahoo News· 2 months agoIonis Pharmaceuticals IONS reported a loss of 98 cents per share for first-quarter 2024, which was...